Healthcare
POMDOCTOR Ltd(POM)
Live Price
Offline$0.072
-17.24% today
Window Change
-98.21%
Window
Oct 8, 2025 → Jun 18, 2026
- Market Cap
- $280.00M
- Revenue Growth
- +12.4%
- EPS Growth
- +1.6%
- Dividend Yield
- 0.0%
Historical coverage is still expanding
This 1Y daily history view is usable, but not fully loaded yet. Additional bars will appear as backfills continue.
Coverage: 174 bars · Oct 8, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
POMDOCTOR Ltd (POM) is a Healthcare stock with a market cap of $280.00M and listed on NASDAQ. The stock last traded around $0.07 and down 98.2% across the available one-year price window (Oct 8, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of +12.4%, EPS growth of +1.6%, a dividend yield of 0.0%. What stands out right now is revenue +12.4%, EPS +1.6%, free cash flow +64.8% with operating margin -7.5% and ROIC 44.0%. Valuation is more restrained than many high-expectation growth names at price/sales 0.8. Stock Foundry combines POM price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+12.4% vs +7.6% peer median
Operating Margin
Below sector median
-7.5% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
The operating story is still moving forward
Revenue is running at +12.4% and EPS at +1.6%, with operating margin around -7.5%.
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
POM
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
POM Max Drawdown
-98.88%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for POM and SPY.
Company Overview
POMDOCTOR Ltd
NASDAQ Global Market
Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China. The company focuses on chronic disease management and pharmaceutical services and offers platform for medical services, which connects patients to doctors and pharmaceutical products. The company's business primarily consists of internet hospital and pharmaceutical supply chain, connecting users, pharmacies, suppliers, medical professionals, and other healthcare participants. The company was founded in 2010 and is headquartered in Guangzhou, China.
- Leadership
- Zhenyang Shi
- IPO Date
- Oct 8, 2025
- Employees
- 156
- Street Address
- Yongxu Industrial Park
- Mailing
- Guangzhou, 510000
- Region
- Guangzhou, CN
- Reporting Currency
- USD
- Investor Line
- 86 20 6231 2277
- Last Updated
- May 3, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- —
- EV/EBITDA
- —
- Price/Sales
- 0.8
- Price/Book
- —
Growth
- Revenue
- +12.4%
- EPS
- +1.6%
- Free Cash Flow
- +64.8%
Profitability
- Gross Margin
- 13.9%
- Operating Margin
- -7.5%
- Net Margin
- -41.9%
- ROE
- 6.5%
- ROIC
- 44.0%
Balance Sheet
- Debt/Equity
- —
- Current Ratio
- 0.21
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.